Kleo Pharmaceuticals Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 24

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $20M

  • Investors
  • 1

Kleo Pharmaceuticals General Information

Description

Developer of immunotherapy compounds designed to emulate and enhance biologics against cancer. The company's compounds are non-immunogenic, highly stable, lower in molecular weight, much faster, and less costly to design and produce which engage the body's immune system to target cancer cells, thereby enabling medical practitioners to begin cancer tumor treatments quickly for a higher likelihood of successful treatment.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 25 Science Park
  • Suite 2D
  • New Haven, CT 06511
  • United States
+1 (203)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Acquirer
Vertical(s)
Corporate Office
  • 25 Science Park
  • Suite 2D
  • New Haven, CT 06511
  • United States
+1 (203)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Kleo Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Merger/Acquisition 04-Jan-2021 $20M Completed Generating Revenue
7. Grant 08-Jul-2020 Completed Generating Revenue
6. Debt - PPP 03-May-2020 Completed Generating Revenue
5. Debt - General 09-May-2019 Completed Generating Revenue
4. Early Stage VC (Series B) 13-Nov-2018 Completed Generating Revenue
3. Early Stage VC (Series A) 03-May-2017 Completed Generating Revenue
2. Grant 31-Dec-2015 $50K Completed Generating Revenue
1. University Spin-Out 01-Jan-2015 Completed Startup
To view Kleo Pharmaceuticals’s complete valuation and funding history, request access »

Kleo Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of immunotherapy compounds designed to emulate and enhance biologics against cancer. The company's compounds a
Drug Discovery
New Haven, CT
24 As of 2021

Plymouth Meeting, PA
 

Houston, TX
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Kleo Pharmaceuticals Competitors (37)

One of Kleo Pharmaceuticals’s 37 competitors is Inovio Pharmaceuticals, a Corporation company based in Plymouth Meeting, PA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Inovio Pharmaceuticals Corporation Plymouth Meeting, PA
Memgen Venture Capital-Backed Houston, TX
Genentech Formerly VC-backed South San Francisco, CA
Arno Therapeutics Formerly VC-backed Flemington, NJ
Pyxis Oncology Formerly VC-backed Boston, MA
You’re viewing 5 of 37 competitors. Get the full list »

Kleo Pharmaceuticals Patents

Kleo Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2020388383-A1 Directed conjugation technologies Pending 18-Nov-2019
CA-3160681-A1 Directed conjugation technologies Pending 18-Nov-2019
EP-4061425-A1 Directed conjugation technologies Pending 18-Nov-2019
EP-4061425-A4 Directed conjugation technologies Pending 18-Nov-2019
US-20230128688-A1 Directed conjugation technologies Active 18-Nov-2019 A61K47/6889
To view Kleo Pharmaceuticals’s complete patent history, request access »

Kleo Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Kleo Pharmaceuticals Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Connecticut Innovations Venture Capital Minority
Gates Foundation Not-For-Profit Venture Capital
PeptiDream Corporation Minority
To view Kleo Pharmaceuticals’s complete investors history, request access »

Kleo Pharmaceuticals FAQs

  • When was Kleo Pharmaceuticals founded?

    Kleo Pharmaceuticals was founded in 2015.

  • Where is Kleo Pharmaceuticals headquartered?

    Kleo Pharmaceuticals is headquartered in New Haven, CT.

  • What is the size of Kleo Pharmaceuticals?

    Kleo Pharmaceuticals has 24 total employees.

  • What industry is Kleo Pharmaceuticals in?

    Kleo Pharmaceuticals’s primary industry is Drug Discovery.

  • Is Kleo Pharmaceuticals a private or public company?

    Kleo Pharmaceuticals is a Private company.

  • What is the current valuation of Kleo Pharmaceuticals?

    The current valuation of Kleo Pharmaceuticals is .

  • What is Kleo Pharmaceuticals’s current revenue?

    The current revenue for Kleo Pharmaceuticals is .

  • How much funding has Kleo Pharmaceuticals raised over time?

    Kleo Pharmaceuticals has raised $51M.

  • Who are Kleo Pharmaceuticals’s investors?

    Connecticut Innovations, Gates Foundation, and PeptiDream have invested in Kleo Pharmaceuticals.

  • Who are Kleo Pharmaceuticals’s competitors?

    Inovio Pharmaceuticals, Memgen, Genentech, Arno Therapeutics, and Pyxis Oncology are some of the 37 competitors of Kleo Pharmaceuticals.

  • When was Kleo Pharmaceuticals acquired?

    Kleo Pharmaceuticals was acquired on 04-Jan-2021.

  • Who acquired Kleo Pharmaceuticals?

    Kleo Pharmaceuticals was acquired by Biohaven.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process